Key result
Paravalvular aortic regurgitation ≥grade II after transfemoral TAVI was an independent predictor of mid-term all-cause mortality.
Why the study?
Paravalvular aortic regurgitation is an important independent predictor of mortality in TAVI, but its relationship with mid-term mortality across the learning curve needed evaluation.
Does paravalvular aortic regurgitation ≥grade II increase mid-term mortality in patients with severe aortic stenosis undergoing transfemoral TAVI?
Cohort
Does paravalvular aortic regurgitation ≥grade II increase mid-term mortality in patients with severe aortic stenosis undergoing transfemoral TAVI?
Answers are grounded in this paper and cite their sources.
Paravalvular aortic regurgitation ≥grade II is an independent predictor of mid-term mortality after TAVI, with its incidence declining after the first 60 cases of a new program's learning curve.
OBJECTIVE: Paravalvular aortic regurgitation is an important independent mortality predictor in transcatheter aortic valve implantation (TAVI). Our study evaluated the association between paravalvular aortic regurgitation and mid-term mortality in relation with the learning curve, in patients with severe aortic stenosis who underwent transfemoral TAVI in the first 3 years since the establishment of the program. METHODS: Patients with severe aortic stenosis who underwent transfemoral TAVI between 2017 and 2020 were included in the analysis. Paravalvular aortic regurgitation was assessed by transthoracic echocardiography at 48 hours after the procedure. All-cause mortality was evaluated after 30 days and at mid-term follow-up. RESULTS: Paravalvular aortic regurgitation ≥grade II was associated with mid-term all-cause mortality (OR 4.4; 95%CI 1.82-11.55; p < 0.001), their prevalence declining after the first 60 cases. Baseline characteristics did not significantly differ in the first 60 patients from the rest of the cohort. Male sex (p = 0.006), advanced age (p = 0.04), coronary artery disease (p = 0.003), or elevated STS Score (p = 0.02) influenced mid-term survival. When adjusting for the presence of these factors, only age (OR 1.1; 95%CI 1.0-1.2), paravalvular aortic regurgitation ≥grade II (OR 3.9; 95%CI 1.3-12.9), and the number of days spent in the intensive care unit (OR 1.4; 95%CI 1.1-1.8) were independent predictors of mid-term all-cause mortality. CONCLUSIONS: In a group of patients with severe aortic stenosis who underwent transfemoral TAVI in the first 3 years since the establishment of the program, paravalvular aortic regurgitation ≥grade II was associated with mid-term mortality, both declining after the first 60 cases.
No takes yet. Share an insight, caveat, or question.
Istrate et al. (2022) conducted a cohort in Severe aortic stenosis. Paravalvular aortic regurgitation ≥grade II vs. Paravalvular aortic regurgitation <grade II was evaluated on Mid-term all-cause mortality (OR 3.9, 95% CI 1.3-12.9). Paravalvular aortic regurgitation ≥grade II after transfemoral TAVI was an independent predictor of mid-term all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: